Back to search

Article

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

2022-01-11

Abstract excerpt

<title>Abstract</title> <p>Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been recorded since January 2020. Over this time global vaccine programs have been introduced, contributing to lowered COVID-19 hospitalisation and mortality rates, particularly in the first world. In late 2021, the Omicron (B.1.1.529) virus variant emerged, with significant genetic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f76ec5d-65fc-599f-9eba-fa3e59b57647
DOI
10.21203/rs.3.rs-1207364/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concernDOI 10.21203/rs.3.rs-1207364/v1
Select a neighboring publication to make it the new centre.